17 results
20-F/A
2020 FY
BPTS
Biophytis
28 Oct 21
Annual report (foreign) (amended)
5:16pm
suspend or terminate a clinical study based on evolving business objectives and/or competitive climate.
Submission of an NDA to the FDA
Assuming
20-F
2020 FY
BPTS
Biophytis
12 Mar 21
Annual report (foreign)
2:38pm
objectives and/or competitive climate.
Submission of an NDA to the FDA
Assuming successful completion of all required testing in accordance with all
424B4
99hbnje9t43ys4
11 Feb 21
Prospectus supplement with pricing info
12:00am
F-1/A
ygq1psl z02fmsqg5p8
4 Feb 21
Registration statement (foreign) (amended)
2:42pm
F-1/A
7d0ah3pr9ef8l szdpw
2 Feb 21
Registration statement (foreign) (amended)
5:27pm
F-1
hnpenpn71x
19 Jan 21
Registration statement (foreign)
5:05pm
DRS/A
jp064xhzjyg npmy1
23 Dec 20
Draft registration statement (amended)
12:00am
DRS
kx0ipohq5ft2cfktt
20 Nov 20
Draft registration statement
12:00am
F-1/A
bmfll3a
11 Jul 19
Registration statement (foreign) (amended)
5:32pm
F-1/A
hrh1uymh
8 Jul 19
Registration statement (foreign) (amended)
5:15pm
F-1/A
tj0535
24 Jun 19
Registration statement (foreign) (amended)
4:31pm
F-1/A
8pzzls1qr6dr n7gz
12 Jun 19
Registration statement (foreign) (amended)
5:19pm
F-1
ox6yb
21 May 19
Registration statement (foreign)
9:06pm
DRS
yxj vhkbc9muxn
25 Feb 19
Draft registration statement
12:00am
- Prev
- 1
- Next